INTRODUCTION
============

Secondary metabolites of filamentous fungi are of extreme interest to humankind due to their pharmaceutical and/or toxic properties ([@b6]). Cyclosporin 'A' is a main product of secondary metabolism of fungal species originally identified as strains of *Trichoderma polysporum* ([@b12]) but currently classified as belonging to the species *Tolypocladium inflatum.* Other soil inhabiting filamentous fungi like *Fusarium solani* ([@b26]) *Neocosmospora vasinfecta* ([@b24]) and *Fusarium oxysporum* ([@b13]) have also been reported to produce lower levels of cyclosporins. Recently, different strains of *A. terreus* have been identified as new producers of cyclosporine 'A' ([@b27], [@b28]).

Cyclosporin 'A' is a nonpolar cyclic peptide of eleven amino acids with a molecular weight of 1202.6. It exhibits a narrow spectrum of antifungal activity and in addition has immunosuppressant properties ([@b12]). This is a strong and selective immunosuppressant in transplant surgery inhibiting the rejection of allogeneic grafts and is also a very promising drug against autoimmune and parasitic diseases ([@b8]). In addition this is applied in reversing multidrug resistance in several types of cancers ([@b11]).

The drug is produced by submerged culturing of aerobic filamentous fungi ([@b17]). Workers have also isolated the enzyme fraction from *T. inflatum* extracts ([@b5], [@b18]). Fermentation conditions ([@b21]) and nutrient medium have already been optimized for the production of cyclosporin 'A' by *T. inflatum.* Some workers obtained best production of the drug from *T. inflatum* by exploiting sorbose in their fermentation media ([@b2], [@b15]) while others found glucose and yeast extract to be best carbon and nitrogen sources ([@b16]). Investigation by Sallam *et al.* ([@b28]) for cyclosporin 'A' production by *A. terreus* revealed that glucose, bactopeptone, pH 5.3 incubated with 2% standard inoculum of 48 hour age, shaken at 200 rpm for 10 days are the best fermentation condition.

Cyclosporin 'A' production was significantly influenced by the addition of amino acids ([@b16], [@b19]). The external addition of L-leucine and L-valine during exponential growth phase highly increased the production of cyclosporin 'A' ([@b1], [@b3]). The productivity from *T. inflatum* was markedly increased by utilizing immobilized fungus ([@b20], [@b22]) in the presence of L-valine ([@b9], [@b10]). Sallam *et al.* ([@b27]) investigated the formation of cyclosporin 'A' by immobilizing the spores and mycelium of *A. terreus* and found L-valine to increase the production. The current study is conducted to detect high yielding strains of *A. terreus* among several local isolates and enhance the production powers of local isolate by altering carbon and nitrogen sources in nutritional medium.

MATERIALS AND METHODS
=====================

Procurement of fungal strains
-----------------------------

Nine strains of *A. terreus* were obtained from the First Fungal Culture Bank of Pakistan (FCBP). The strains were preserved on Malt Extract Agar (MEA) at 4 ºC and were provided in the form of slants in culture tubes. The strains were revived on MEA plates (malt extract 2 %, agar 2 %, pH 6.5) and the inoculated plates were incubated at 27±1 ºC for 4--5 days. The strain numbers and their origins of isolation are mentioned in [Table 1](#tbl1){ref-type="table"}.

###### 

*Aspergillus terreus* strain numbers and their origin of isolation.

  Strain no.   Origin of isolation
  ------------ -------------------------------------------
  FCBP58       Soil, canal bank Lahore
  FCBP113      Air mycoflora, NIAB
  FCBP119      Air microflora, Punjab university Lahore.
  FCBP122      *Dalbergia sissoo* root
  FCBP148      Air microflora, Punjab university Lahore
  FCBP168      Air microflora, Punjab university Lahore
  FCBP196      Air microflora, Punjab university Lahore
  FCBP536      Air microflora, Punjab university Lahore
  FCBP652      Soil, Lahore

Seed inoculum preparation
-------------------------

Seed inoculum was prepared in Malt Yeast extract (MY) medium (malt extract 2 %, yeast extract 0.4 %, initial pH of 5.7). A 0.8 cm disk of five days old strain culture was inoculated in sterilized medium and incubated on orbital shaker at 200 rpm for 72 hours at 30±2 ºC ([@b7]).

Cultivation
-----------

According to the method of Agathos *et al.* ([@b2]) the flasks containing 50mL of production medium (glucose 5 %, peptone 1 %, KH~2~PO~4~ 0.5 %, KCl 0.25 %, pH 5.3 as designed by Sallam *et al.* ([@b28]) were inoculated with 5 mL of prepared seed inoculum (i.e. 10 % v/v). The inoculated flasks were incubated on orbital shaker at 200 rpm at 30±2 ºC for 10 days.

Extraction of cyclosporin 'A'
-----------------------------

The extraction of cyclosporin 'A' was performed by using n-butyl in equal quantity in the medium and flasks were incubated at 200 rpm and 30±2 ºC for 24 hours. Two distinguish immiscible layers of top organic phase and bottom aqueous phase were formed containing extraction solution and medium respectively. The organic phase was carefully separated by using separating funnel and evaporated under vacuum till dryness at 40 ºC. The dried sample was weighed and dissolved in 30 mL methanol.

Biomass harvest
---------------

The biomass was harvested by filtering aqueous layer of cultivation medium containing fungal pellets using Whatman filter paper No.1. The biomass was dried in oven overnight at 40 ºC and was weighed.

Analysis and Estimation of cyclosporin 'A'
------------------------------------------

**Antifungal bioassay:** The antifungal bioassay was performed against *Aspergillus niger* FCBP74 isolated from air mycoflora, Punjab University, Lahore by well method. The inhibition zone was measured by measuring diameter from eight different sides and taking the mean.

**High performance liquid chromatography (HPLC):** High performance liquid chromatography (HPLC) was done for detection and estimation of cyclosporin 'A'. Hitachi HPLC system equipped with UV-VIS detector (L-2420) and pump (L-2130) was used for detection and estimation of cyclosporine 'A' under the following operating conditions: Mobile phase consisted of acetonitrile: methanol: water (42.5: 20: 37.5), Flow rate of 0.8 mL/min, C~18~ column, wavelength of 215 nm. 20 μl of diluted samples and standard samples were injected in the HPLC system. The standards were 100 mg capsules of Sandimmun Neoral^®^ (Novartis) and ≥ 98.5 % pure authentic sample of cyclosporin 'A' purchased from Fluka Analytical, Japan. The following formula was used to determine cyclosporin 'A' level in crude extracts ([@b23]).
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Where, As is peak area of sample, Ar is peak area of reference, Wr is weight of reference material in grams, Ws is weight of sample in grams, Vs is volume of sample, Vr is volume of reference material. The areas of sample peaks and of reference peak were calculated from the chromatograms obtained by HPLC program LaChrom Elite.

Optimization of medium composition
----------------------------------

The selected *A. terreus* FCBP58 strain was grown on different medium to achieve an increased yield of cyclosporin 'A'. Previously used cultivation medium containing glucose 5 %, peptone 1 %, KH~2~PO~4~ 0.5 %, KCl 0.25 % and initial pH of 5.3 as designed by Sallam *et al.* 2003 was altered by using different carbon and nitrogen sources.

Three sets of media were tested for production of cyclosporin 'A'. In the first set, six carbon sources i.e. glycerol, glucose, maltose, fructose, sucrose and cellulose were used in four different concentrations of 1, 2, 5 and 10 % (w/v) in replacement of glucose 5 %. In the second set of production medium, Peptone, trypton and casamino acids in concentrations of 0.5, 1.0, 1.5 and 2.0 % (w/v) were used in place of peptone 1 %. Four different amino acids (asparagine, tyrosine, valine and leucine) in concentrations of 0.1, 0.2, 0.4 and 0.6 % (w/v) were supplemented to the medium in the third set.

A 5mL of prepared seed inoculum was inoculated in the prepared cultivate media of different sets and incubated on orbital shaker at 200 rpm and 30±2 ºC for 10 days. The extraction, analysis and estimation of cyclosporin 'A' was performed by the same procedure as described above for the selection of best yielding strain.

RESULTS AND DISCUSSION
======================

Screening of fungal strains
---------------------------

Present study was conducted to design a production media most conducive for cyclosporin 'A' production using *A. terreus* strain. In the first step nine isolates of the selected fungal species were checked for the drug production. The strains isolated from soil i.e., FCBP652, FCBP122 and FCBP58 produced maximum quantities of cyclosporin 'A'. The highest production reached to 62.4 μg/mL by FCBP58 ([Fig. 1](#fig1){ref-type="fig"}) as shown in [Table 2](#tbl2){ref-type="table"}. This quantity was much lower than 105.5mg/L recorded by Dreyfuss *et al.* ([@b12]) and Agathos *et al.* ([@b2]), and 183mg/L recorded by Balakrishan and Pandey, ([@b3]) by most studied fungal strain *T. inflatum.* Sallam *et al.* ([@b28]) also recorded higher productivity of 86.57 mg/L by an isolate of *A. terreus.* The project was therefore planned to enhance the production potential of FCBP58 for increased drug production.

![Culture of indigenous strain of *Aspergillus terreus* FCBP58 (left) and harvested mixture from *Aspergillus terreus* FCBP58 (right).](bjm-42-1374-g001){#fig1}

###### 

Cyclosporin 'A' production by nine different Aspergillus terreus strains.

  Strains   Peak area   dry weight   \% Cyclosporin   wt. of   wt. of
  --------- ----------- ------------ ---------------- -------- ---------------
  FCBP58    9,585,692   32           9.76             3.12     \*62.4 ± 2.89
  FCBP113   5,190,782   22           7.69             1.69     33.38 ± 1.16
  FCBP119   1,290,593   36           1.13             0.30     6.0 ± 1.85
  FCBP122   8,447,103   25           11.04            2.76     55.2 ± 2.6
  FCBP148   8,586,308   27           10.43            2.81     56.2 ± 1.85
  FCBP168   5,031,317   33           4.95             1.63     32.6 ± 1.5
  FCBP196   2,327,129   27           2.77             0.74     14.80 ± 0.75
  FCBP536   6,042,242   40           4.95             1.98     39.60 ± 2.08
  FCBP652   7,857,211   30           8.51             2.55     51 ± 1.74

Confirmation of cyclosporin 'A'
-------------------------------

Cyclosporin-related metabolites are reported to have a broad spectrum of antifungal activity and a narrow spectrum of activity against bacterial cultures ([@b25]). The harvested mixture assumed to have cyclosporins showed strong antifungal activity against *A. niger* when tested through well method. The inhibition zone of restricted growth of *A. niger* was 1.15 cm ([Fig. 2](#fig2){ref-type="fig"}).

![Antifungal activity bioassay of cyclosporin 'A' against *Aspergillus niger.* Control of *Aspergillus niger* without extracted liquid (right). Inhibition zone of *Aspergillus niger* treated with extracted liquid of cyclosporin like compounds.](bjm-42-1374-g002){#fig2}

When run through HPLC, a peak appeared between 2.7 and 2.8 min ([Fig. 5](#fig5){ref-type="fig"}), which was confirmed as cyclosporin 'A' when compared with Sandimmun Neoral^®^ capsules containing 100 mg cyclosporin 'A' as active ingredient and pure cyclosporine 'A' as authentic drug supplied by Fluka analytical, Japan. Sandimmun Neoral^®^ capsules showed a clear peak at 2.768 min ([Fig. 3](#fig3){ref-type="fig"}) whereas authentic compound recorded at 2.81 min ([Fig. 4](#fig4){ref-type="fig"}).

###### 

HPLC chromatograms of metabolites from selected strains of *Aspergillus terreus*. The peak appearing between 2.7--2.8 minutes in chromatograms extracted at 215nm has been identified as cyclosporin 'A' where as A: FCBP58; B: Glucose 10%; C: Peptone 0.5%; D: Valine 0.1%.

![](bjm-42-1374-g005)

![](bjm-42-1374-g005a)

![HPLC chromatogram of Sandimmun Neoral^®^ capsule (Novartis) 100mg cyclosporin as active ingredient extracted at 215nm. Peak at 2.7min is of cyclosporin 'A'.](bjm-42-1374-g003){#fig3}

![HPLC chromatogram of authentic cyclosporin 'A' purchased from Fluka analytical, Japan. The chromatogram extracted at 215nm is showing cyclosporin 'A' peak at 2.8min.](bjm-42-1374-g004){#fig4}

Effect of carbon source
-----------------------

Six different carbon sources were tried in this study to augment the drug production ([Table 3](#tbl3){ref-type="table"}). Highest tested concentration was 10 % at which when glucose was added, it proved to be the most effective carbon source significantly increasing cyclosporin 'A' production up to 358.5 μg/mL ([Fig. 5B](#fig5){ref-type="fig"}). This shows that *A. terreus* can utilize this sugar most efficiently as primary source as it is a hexose monosaccharide and is a primary source of energy for most of the living organisms including fungi. Balakrishnan and Pandey ([@b3]) stated that by using *T. inflatum* the best yield of cyclosporin 'A' can be obtained on a medium consisting of 20 g/L glucose. In a contemporary study Balaraman and Mathew ([@b4]) obtained maximum cyclosporin 'A' production with medium containing 8 % glucose. In a research conducted by Sallam *et al.* ([@b28]) on *A. terreus,* the medium containing 50 g/L glucose produced a maximum yield (86.77 mg/L) of cyclosporin 'A'.

###### 

Effect of different carbon sources and their concentrations on the production of cyclosporin 'A' by Aspergillus terreus FCBP58.

  Treatment      Peak area    Weight of dry biomass (g/50mL)   Weight of dry extract (mg/50mL)   Cyclosporin 'A' productivity                                   
  -------------- ------------ -------------------------------- --------------------------------- ------------------------------ ------- -------------- -------- --------
  Cellulose 1%   666,767      0.66                             53                                0.41                           0.22    4.40 ± 0.6     -58      -93.0
  Cellulose 2%   35,686,578   0.97                             50                                23.52                          11.76   235.0 ± 4.6    172.6    276.6
  Cellulose 5%   23,291,007   2.07                             55                                13.82                          7.60    152.0 ± 2.9    89.6     143.6
  Cellulose10%   1,197,291    4.81                             14                                2.78                           0.39    7.8 ± 0.5      -54.6    -87.5
  Fructose 1%    836,205      0.23                             37                                0.73                           0.27    5.4 ± 0.5      -57.0    -91.3
  Fructose 2%    1,315,461    0.33                             37                                1.13                           0.42    8.4 ± 0.6      -54.0    -86.5
  Fructose 5%    4,616,043    0.86                             64                                2.34                           1.50    30.0 ± 1.7     -32.4    -51.9
  Fructose 10%   3,727,318    0.93                             67                                1.68                           1.126   22.52 ± 0.8    -39.8    -63.9
  Glucose 1%     5,562,128    0.26                             17                                10.76                          1.83    36.6 ± 1.2     -25.9    -41.3
  Glucose 2%     3,047,128    0.45                             42                                2.4                            1.008   20.16 ± 0.7    -42.24   -67.7
  Glucose 5%     8,076,613    0.84                             49                                5.38                           2.63    52.60 ± 2.0    -9.8     -15.70
  Glucose 10%    54,475,949   1.18                             49                                36.59                          17.9    358.50 ± 7.5   296.1    473.71
  Glycerol 1%    1,496,101    0.28                             52                                0.92                           0.47    9.56 ± 0.7     -52.84   -84.7
  Glycerol 2%    1,884,342    0.44                             53                                1.128                          0.59    11.80 ± 1.9    -50.6    -81.08
  Glycerol 5%    7,103,458    0.78                             82                                2.83                           2.32    46.40 ± 2.9    -16.0    -25.64
  Glycerol 10%   3,146,050    0.92                             73                                1.40                           1.022   20.40 ± 1.3    -42.0    -67.30
  Maltose 1%     1,908,806    0.25                             33                                1.8                            0.59    11.88 ± 0.5    -50.5    -81.0
  Maltose 2%     791,223      0.43                             50                                0.52                           0.26    5.20 ± 0.8     -57.2    -91.7
  Maltose 5%     2,581,235    0.89                             111                               0.764                          0.84    16.80 ± 1.2    -45.6    -73.1
  Maltose 10%    3,894,098    1.60                             62                                2.05                           1.27    25.40 ± 2.0    -37      -59.29
  Sucrose 1%     4,159,694    0.242                            47                                2.90                           1.36    27.26 ± 1.9    -35.14   -56.3
  Sucrose 2%     1,813,249    0.405                            57                                1.044                          0.59    11.90 ± 0.9    -50.5    -80.92
  Sucrose 5%     4,763,647    1.028                            87                                1.792                          1.55    31.18 ± 2.0    -31.22   -50.03
  Sucrose 10%    42,053,580   1.635                            44                                31.46                          13.84   276.80 ± 8.7   214.4    343.58

Beside glucose, cellulose also proved a fairly good carbon source in case of *A. terreus*, when used in concentration of 2 %, it increased cyclosporin 'A' production from 62.4 µg/mL to 235 µg/mL ([Table 3](#tbl3){ref-type="table"}). Increase in concentration to 5 % result in 143.6 % increase in cyclosporin 'A' production. However it was lower in comparison to the treatment in which cellulose 2 % was used. Although cellulose is a complex carbohydrate (polysaccharide), but *A. terreus* is known to produce extracellular endo-β-1, 4-glucanase, exo-β-1, 4-glucanase with high levels of β- glucosidase and has the ability to utilize cellulose as carbon source. Previous studies also show increase in fungal biomass with increase of carbon sources ([@b29]).

Effect of nitrogen sources
--------------------------

Peptone, trypton and casamino acids was used individually and then in combinations to check the productivity of cyclosporin 'A' ([Table 4](#tbl4){ref-type="table"}). These three compounds are amino acid mixtures. Peptone when checked at lower concentration of 0.5 %, increased drug production spectacularly by 765.4 % ([Fig 5C](#fig5){ref-type="fig"}). Peptones are derived from animal milk or meat digested by proteolytic digestion and contains small peptides along with fats, metals, salts, vitamins and many other biological compounds. As peptone can provide vitamins and metals along with amino acids it proved best supplement for drug enhancement in comparison to others.

###### 

Effect of different nitrogen sources and their concentrations on the production of cyclosporin 'A' by Aspergillus terreus FCBP58.

  Treatment             Peak area    Weight of dry   Weight of dry extract   Cyclosporin 'A' productivity                                   
  --------------------- ------------ --------------- ----------------------- ------------------------------ ------- -------------- -------- --------
  Casamino acids 0.5%   16,364,563   0.628           66                      8.0                            5.28    105.60 ± 3.0   43.2     69.2
  Casamino acids 1.0%   8,379,095    0.595           42                      6.56                           2.75    55.0 ± 2.7     -7.4     -11.9
  Casamino acids 1.5%   15,604,075   0.722           70                      7.14                           4.99    99.96 ± 3.6    37.56    60.2
  Casamino acids 2.0%   7,232,184    0.767           27                      8.77                           2.37    47.40 ± 2.1    -15      -24.0
  Peptone 0.5%          83,134,204   0.69            66                      40.95                          27.0    540.0 ± 8.1    477.6    765.4
  Peptone 1.0%          9,701,506    0.964           94                      3.63                           3.41    68.2 ± 1.7     5.8      9.29
  Peptone 1.5%          11,153,821   1.595           113                     3.25                           3.67    73.40 ± 2.0    11       17.62
  Peptone 2.0%          8,809,388    0.714           104                     2.78                           2.90    58.0 ± 2.1     -4.4     -7.05
  Trypton 0.5%          18,545,336   0.542           78                      7.68                           5.99    119.80 ± 5.4   57.4     92.0
  Trypton 1.0%          16,458,531   0.48            43                      12.42                          5.34    106.80 ± 3.7   44.4     71.1
  Trypton 1.5%          8,626,905    0.585           21                      13.5                           2.83    56.60 ± 1.9    -5.8     -9.3
  Trypton 2.0%          12,679,379   0.705           38                      10.92                          4.15    83.0 ± 2.4     20.6     33.0
  Asparagine 0.1%       9,542,019    0.756           61                      5.0                            3.07    61.48 ± 3.1    -0.92    -1.5
  Asparagine 0.2%       10,616,702   0.855           40                      8.77                           3.5     70.16 ± 3.7    7.76     12.43
  Asparagine 0.4%       9,223,835    0.69            41                      7.2                            3.0     59.86 ± 3.2    -2.54    -4.1
  Asparagine 0.6%       4,202,735    0.746           62                      2.2                            1.36    27.20 ± 2.1    -35.2    -56.41
  Leucine 0.1%          3,549,633    0.55            52                      2.22                           1.15    23.0 ± 1.8     -39.4    -63.1
  Leucine 0.2%          2,883,930    0.637           47                      2.02                           0.95    19.0 ± 1.7     -43.4    -69.6
  Leucine 0.4%          2,510,248    0.678           53                      1.57                           0.83    16.64 ± 1.5    -45.7    -73.3
  Leucine 0.6%          1,278,554    0.669           55                      0.76                           0.42    8.36 ± 1.4     -54.0    -86.6
  Tyrosine 0.1%         1,441,381    0.778           41                      1.14                           0.47    9.34 ± 1.5     -53.06   -85.0
  Tyrosine 0.2%         2,397,367    0.793           54                      1.4                            0.456   15.12 ± 2.1    -47.28   -75.76
  Tyrosine 0.4%         1,247,816    0.994           45                      0.924                          0.415   8.30 ± 0.9     -54.1    -86.69
  Tyrosine 0.6%         1,700,814    0.888           60                      0.90                           0.54    10.80 ± 1.0    -51.6    -82.69
  Valine 0.1%           14,193,755   0.781           47                      9.82                           4.61    92.20 ± 5.0    29.8     47.75
  Valine 0.2%           5,316,042    0.837           41                      4.176                          1.7     34.0 ± 2.0     -28.4    -45.51
  Valine 0.4%           12,729,486   0.803           47                      8.81                           4.14    82.81 ± 2.4    20.41    32.70
  Valine 0.6%           7,493,167    0.817           61                      3.93                           2.40    48.0 ± 1.4     -14.4    -23.07

Note: All the data in table III & IV is compared with cyclosporin 'A' produced by FCBP58 (62.4μg/mL) and given as means ± standard error.

Trypton also enhanced the drug production by 92 % and 71.1 % when used in 0.5 and 1 % concentrations respectively. Although the percentage of enhancement was much lower to that of peptone, but this increase was observed at almost all the tested concentrations. Trypton is commonly used in microbiology to produce Lysogeny broth for the growth of microorganisms and provides a source of amino acids for the growing bacteria. Trypton is similar to casamino acids, both being digests of casein, but casamino acids can be produced by acid hydrolysis and typically only have free amino acids and few peptide chains. Casamino acids in concentration of 0.5 % and 1.5 % significantly increased cyclosporin 'A' production by 69.2 % and 60.2 % respectively when compared to the value recorded in unmodified production medium.

The fungal production of peptide and depsipeptide antibiotics may be directed and enhanced by amino acid components of the antibiotic molecule. Kobel and Traber ([@b17]) reported the direct synthesis of cyclosporin 'A' and several analogues in fermentations where the composition and titre of each analogue produced were strongly determined by the kind of externally supplemented amino acid. Accordingly, four amino acids asparagine, leucine, tyrosine and valine were tested for their drug enhancing effect. Valine showed enhancing effect on cyclosporin 'A' production, when used in 0.1 and 0.4 % concentration ([Fig. 5D](#fig5){ref-type="fig"}). Similar results were obtained by Balakrishan and Pandey ([@b3]) when they found L-leucine and L-valine as strong inducers of cyclosporin 'A'. They also noticed that D-valine had no stimulatory effect on drug production. Also the presence of amino acids in the exponential growth phase ensured optimal production, as was indicated in an experiment, in which L-valine was added at different times.

However, in agreement with these workers, an increase in total cyclosporine production was seen, but of considerably higher magnitude. L-valine may have a role of inducer to increase the transcription of genes for cyclosporin 'A' synthetase or other structural genes contributing to cyclosporin 'A' synthesis in our fungal strain, given the positive effect of the amino acid when added early in the fermentation. Some amino acids may act as inducers which must be added in exponential growth phase to manifest their ability to enhance secondary metabolite production. It is also possible that these amino acids may direct cell development in a manner favouring secondary metabolite production by affecting transcription of secondary metabolite genes during vegetative cell growth ([@b14]).

The results showed that the modification of production medium by increasing glucose concentration to 10 % as carbon source and addition of lower peptone concentration of 0.5 % as nitrogen source along with valine (0.1 %) supplementation can significantly increase cyclosporin 'A' production.

Drug production versus fungal biomass
-------------------------------------

When increase in fungal biomass produced by selected strain in various modified media was compared to the increment of cyclosporin 'A' the drug production was not found directly associated with increase in biomass ([Fig. 6](#fig6){ref-type="fig"}--[8](#fig8){ref-type="fig"}). Similar results have been reported by earlier workers. Sallam *et al.* ([@b28]) reported that biomass yield and hence the volumetric production of cyclosporin 'A' increased linearly when they changed initial pH of the medium from 3.3 to 5.3, however further increase in pH increased biomass of *A. terreus* but considerably decreased drug production. An exception was observed in case of glucose, when it supplied as a sole carbon source its increase in concentration increased biomass of *A. terreus* and so the drug production.

![Effect of different carbon sources and their concentrations on production of cyclosporin 'A' and fungal biomass in production medium (values are mean ± SE of 3 observations).](bjm-42-1374-g006){#fig6}

![Effect of different nitrogen sources and their concentrations on production of cyclosporin 'A' and fungal biomass in production medium (values are mean ± SE of 3 observations).](bjm-42-1374-g007){#fig7}

![Effect of different amino acids and their concentrations on production of cyclosporin 'A' and fungal biomass in production medium (values are mean ± SE of 3 observations).](bjm-42-1374-g008){#fig8}

Drug production versus extract colour
-------------------------------------

The colour of the final extract containing cyclosporins showed variation from light yellow to dark reddish orange. However, the darkness of colour also did not seem to correspond with any increment in amount of cyclosporin 'A'. In case of glucose, increase in sugar concentration in production medium increased drug production and also the colour intensity. It is supposed that the final extract is a combination of various cyclosporins and may posses some other compounds. The quantity of these compounds also varies with variation in the treatments. This can affect the colour of final extract that do not directly relates to the increase in cyclosporin 'A' production.
